• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

Immunity to COVID in Britain is waning as winter looms, testing expert warns, and there’s no plan for a wide-scale booster program in sight

By
Chloe Taylor
Chloe Taylor
Down Arrow Button Icon
By
Chloe Taylor
Chloe Taylor
Down Arrow Button Icon
August 11, 2022, 8:42 AM ET
The image shows a British nurse in full PPE preparing a COVID vaccine.
The U.K. findings come after America’s top doctor, Anthony Fauci, warned anyone who isn’t up to date with their COVID vaccinations is soon “going to get into trouble.” Jeff J Mitchell—Pool/Getty Images

Rates of high antibody protection are declining in the U.K., prompting warnings that the population will have insufficient immunity levels as it heads into the “dangerous” winter months.

Published Wednesday, new figures from Britain’s Office for National Statistics (ONS) revealed that the number of people with a high level of antibodies against the virus was rapidly dwindling.

Anything above 800 nanograms (ng) of antibodies per milliliter of blood is considered a high level, according to the ONS.

The organization’s latest data revealed that 71.7% of the English population had this high level of antibodies between July 11 and July 17—marking a 1.4% decline from a week earlier.

The data included samples from 10,234 people over the age of 16 living in England.

The picture was similar across Britain, with high antibody rates also declining in Scotland, Wales, and Northern Ireland.

The ONS research dates back to December 2020, when it found that just 0.7% of English adults had high antibody levels.

High antibody levels peaked in March this year, according to the data, when 82% of England’s population had high antibody protection.

Wednesday’s data marked a 12% decline from the March peak in high antibody levels across England.

The ONS noted on Wednesday that its methodology for the study changed in May. However, the trend in the data continued as before.

Meanwhile, the data showed that the U.K.’s baseline antibody level of at least 179 ng per ml of blood—which had been set at the height of the Delta wave of the pandemic—had held firm, with the proportion of the population with this level of antibodies remaining unchanged from a week earlier and showing little change from mid-March.

‘Dangerous’ times ahead

The U.K. was the first country in the world to administer doses of coronavirus vaccines outside of clinical trials in December 2020, and the peak in high antibody levels seen in March came after the country’s booster program was rolled out to all adults.

People over the age of 75 and those with weakened immune systems became eligible for a second booster dose in the spring of this year.

A total of 87.9% of people in the U.K. over the age of 12 have received two doses of a COVID vaccine. Seven in 10 have had a booster shot.

While there are plans for an autumn booster program for certain individuals in Britain, including the over-fifties, frontline health care workers, and the immunosuppressed, no plans have been announced to extend the additional booster doses to the wider population.

A spokesperson for the U.K. government was not immediately available for comment when contacted by Fortune.

Dr. Quinton Fivelman, lead testing expert and chief scientific officer at London Medical Laboratory, said in a press release on Thursday that populations needed to retain a substantial number of antibodies as they entered “the dangerous winter months.”

“This dramatic 12.7% decrease in the number of people in England with a significant number of antibodies to COVID is obviously concerning,” he said.

Fivelman added that less than 70% of people in Britain were now likely to have high levels of antibody protection against COVID-19.

“The simple truth is that, if this rate of decline continues to accelerate and the first U.K. adults don’t start receiving their boosters until October, only 60% of the population will retain substantial antibodies by the time they are jabbed,” he warned.

Fivelman told Fortune that London Medical Laboratory’s research indicated vaccine-derived immunity waned substantially once three months had passed since vaccination. This was true regardless of which vaccine an individual received, he added.

“One developing concern is that the new Omicron BA.4 and BA.5 subvariants do not produce as high an immune response as the previous strains, so reinfection is more likely to occur,” he said. “Higher levels of antibodies are important to neutralize the virus, stopping infection and limiting people transmitting the virus to others.”

Fivelman’s comments echo a warning from America’s top doctor Anthony Fauci last week that anyone who was not up to date with their COVID vaccinations heading into the fall and winter months was “going to get into trouble.”

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Chloe Taylor
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Big TechSocial Media
YouTube’s cofounder and former tech boss doesn’t want his kids to watch short videos, warning short-form content ‘equates to shorter attention spans’
By Marco Quiroz-GutierrezMarch 1, 2026
2 days ago
HealthTikTok
Gen Z men are eating ‘boy kibble,’ the human equivalent to dog food, to load up on protein cheaply
By Jake AngeloMarch 1, 2026
2 days ago
Healthsleep
8 Best Firm Mattresses in 2026: Tested and Reviewed by Sleep Experts
By Christina SnyderFebruary 27, 2026
3 days ago
HealthFood and drink
Chains like Sweetgreen and Chipotle are finally realizing they need to look beyond the ‘slop bowl’
By Phil WahbaFebruary 27, 2026
4 days ago
chat
Healthchat
Here are the 7 rules of group chats, including how to leave when you’ve had enough
By Kelvin Chan and The Associated PressFebruary 27, 2026
4 days ago
will
CommentaryAdvertising
I’m one of America’s top pollsters and I’ve got a warning for the AI companies: customers aren’t sold on ads
By Will JohnsonFebruary 27, 2026
4 days ago

Most Popular

placeholder alt text
Middle East
U.S. military gives Iran a taste of its own medicine with cheap copycat Shahed drones, while concern shifts to munitions supply in extended conflict
By Jason MaMarch 1, 2026
1 day ago
placeholder alt text
Success
MacKenzie Scott's close relationship with Toni Morrison long before Amazon put Scott on the path to give more than $1 billion to HBCUs
By Sasha RogelbergMarch 1, 2026
2 days ago
placeholder alt text
Economy
Your grandparents are the reason the U.S. isn't in a recession right now. That won't last forever
By Eleanor PringleMarch 1, 2026
2 days ago
placeholder alt text
AI
American schools weren’t broken until Silicon Valley used a lie to convince them they were—now reading and math scores are plummeting
By Sasha RogelbergMarch 1, 2026
1 day ago
placeholder alt text
Success
Slack cofounder says workers and CEOs can get stuck doing 'fake' work like pre-meetings and slideshows
By Emma BurleighMarch 1, 2026
2 days ago
placeholder alt text
Health
Gen Z men are eating ‘boy kibble,’ the human equivalent to dog food, to load up on protein cheaply
By Jake AngeloMarch 1, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.